Skip to main content
Clinical Trials/NL-OMON37939
NL-OMON37939
Completed
Not Applicable

Autologous conditioned plasma injection for acute hamstring muscle injury. - Dutch Hamstring Injection Therapy (HIT) study

Arthrex Medizinische Instrumente GmbH0 sites80 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
hamstring rupture
Sponsor
Arthrex Medizinische Instrumente GmbH
Enrollment
80
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Arthrex Medizinische Instrumente GmbH

Eligibility Criteria

Inclusion Criteria

  • 1\.Clinical diagnosis of an acute hamstring injury, defined as:
  • \- anamnestic acute injury
  • \- anamnestic pain in posterior thigh
  • \- localised pain during palpation of hamstring muscle
  • \- localised pain during passive straight leg raising
  • \- increasing pain during isometric contraction
  • 2\.Hamstring lesion proven on MRI (increased signal in injured muscle on T2 and/or STIR)
  • 3\. First injection will be performed maximal 5 days after injury
  • 4\. Informed consent
  • 5\. Age 18\-50 year

Exclusion Criteria

  • 1\.Patient is not capable of doing an active exercise program
  • 2\.Patient has recieved injection therapy for this injury before
  • 3\. Patient does not have the intention to return to full sports activity
  • 4\.Patient does not want to recieve one of the two therapies
  • 5\.Cause of hamstring injury is an extrinsic trauma on posterior thigh
  • 6\.Patient has chronic low back pain
  • 7\.There are contraindications for MRI:pacemaker, pregnancy, claustrofobia
  • 8\.Patient has chronich hamstring complaints (\> 2 months)
  • 9\.There is a grade 3 lesion (total rupture) on MRI

Outcomes

Primary Outcomes

Not specified

Similar Trials